Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GRK2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
mRNA | CH17-140K24.5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | ENTPD8 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
mRNA | MYOZ3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
mRNA | GTF3C1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
mRNA | NKX2-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | NEU2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
mRNA | ID2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | LATS2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
mRNA | ZBTB48 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |